Brightsurf Science News & Current Events

June 03, 2007
Michael R. Zalutsky receives SNM's 2007 Paul C. Aebersold Award
Michael R. Zalutsky, a professor of radiology and biomedical engineering at Duke University in Durham, N.C., received the 2007 Paul C.

Chemotherapy may enhance the effectiveness of brain tumor vaccines
Chemotherapy temporarily hinders the body's immune response, creating a concern that it may interfere with the promising new cancer vaccines being used against brain tumors.

Phase II study shows combination improves survival of metastatic melanoma patients
Two chemotherapy drugs combined with an agent that prevents the growth of blood vessels significantly delayed the spread of tumors in patients with metastatic melanoma.

Harboring hostility may be linked to unhealthy lungs
Young adults with a short temper or mean disposition also tend to have compromised lung function.

SNM recognizes R. Edward Coleman with 2007 Georg Charles de Hevesy Nuclear Pioneer Award
R. Edward Coleman, director of the nuclear medicine division at Duke University Medical Center in Durham, N.C., was awarded the 2007 Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession.

Genetic mutations identified for type of gastric cancer
Researchers have identified novel genetic mutations that are linked to hereditary diffuse gastric cancer, with these mutations being due to both independent mutational events and common ancestry, according to a study in the June 6 issue of JAMA.

Vorinostat shows anti-cancer activity in recurrent gliomas
North Central Cancer Treatment Group researchers, based at Mayo Clinic in Rochester, Minn., report that a novel application of the drug vorinostat shows activity in patients with recurrent glioblastoma multiforme.

Drug shows activity against brain metastases
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial being presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology.

Study finds difference in survival rates among white and black women with advanced breast cancer
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at the University of Texas M.

Treatment for early prostate cancer associated with type of specialist seen
A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.

Fusing imaging technologies creates 'synergy,' helps diagnose heart disease accurately
To fight heart disease, you have to get to the

Tumor cell activity may provide clues for treating breast cancer in young women
When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women.

PET accurately identifies esophageal cancer patients' positive responses to chemotherapy
Early metabolic imaging with positron emission tomography accurately identifies patients responding to chemotherapy for esophageal cancer, noted German researchers at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

New drug development facility helps move medicines to market
Innovative new drugs for obesity, diabetes, pain, cancer and multiple sclerosis are being assisted to market at the University of Queensland by Australia's only

Nonhormonal drug reduces hot flashes in men treated for prostate cancer
North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.

A sound way to turn heat into electricity
University of Utah physicists developed small devices that turn heat into sound and then into electricity.

New insights into the neural basis of anxiety
Researchers from the Mouse Biology Unit of the European Molecular Biology Laboratory in Italy have now uncovered the neural basis for such anxiety behaviour in mice.

Even when child's cancer prognosis is poor, parent/physician communication can provide hope
Physicians who inform parents of children with cancer about the likely course of the disease can provide hope, even when the child's prognosis is poor, according to a Dana-Farber Cancer Institute study to be presented at a press briefing at the American Society of Clinical Oncology annual meeting on Sunday, June 3, at 7:30 a.m.

Exploring better ways to determine when to change the course of treatment
Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made.

Aussie research goes global through new grants
Australian health care researchers will be taking their work to the world, visiting renowned international health research centres as a result of new travelling scholarships.

Every moment counts: Predicting treatment responses earlier for brain tumor patients
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

MUHC-led international team identifies gene responsible for blindness in infants and children
A MUHC-led study identifies a gene responsible for Leber Congenital Amaurosis, the most common cause of congenital blindness in infants and small children.

Herceptin does not increase heart failure in patients long term
Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine.

Adding radioimmunotherapy to chemo may help patients with lymphoma
Patients treated for follicular lymphoma, a slow-growing type of non-Hodgkin's lymphoma, may benefit from chemotherapy followed by radioimmunotherapy, according to a University of Pittsburgh Medical Center study.

Antidepressant does not improve symptoms in advanced cancer patients without major depression
The established antidepressant sertraline does not improve symptoms, well-being or survival in patients with advanced cancer who do not have major depression.

Brain-boosting pill alleviates post-chemotherapy fogginess
A drug described by some people as a is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to